PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer - Wikidata - awgldk - TriplyDB

PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer

PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer

http://www.wikidata.org/entity/Q34768343

about

Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1 Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs PPARγ as a Novel Therapeutic Target in Lung Cancer A review of the past, present, and future directions of neoplasia Neoplasia: Where We Have Been and Where We Are Going Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model Anandamide inhibits breast tumor-induced angiogenesis Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer Involvement of PPAR nuclear receptors in tissue injury and wound repair Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer Peroxisome proliferator-activated receptors and cancer: challenges and opportunities PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Function of PPARgamma and its ligands in lung cancer.Peroxisome proliferator-activated receptors in lung cancer.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-gamma Ligands in Lung Cancer.Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention?Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.Inflammation and lung carcinogenesis: applying findings in prevention and treatment.Thiazolidinediones as anti-cancer agents.Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone.Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.Comprehensive analysis of genes, pathways, and TFs in nonsmoking Taiwan females with lung cancer.Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy.PPARγ disease gene network and identification of therapeutic targets for prostate cancer.Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice.Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.

P2860

Q22299231-7DB578E3-7C08-4182-BE46-9F63F676A069 Q24303556-CC12B960-19BE-494C-A80F-9437363A325D Q26750845-B83EDAD8-E038-450B-B0ED-662DF3BC6927 Q28068114-69D71889-CBBE-46C4-9784-2307D68F7E6B Q28389391-86F28A48-788C-42CD-B672-88382496C63B Q28395095-9C903ADC-36E6-44D0-9EB3-DB4903ADCC55 Q33692555-2F74AE31-B8CC-4B89-834A-BCCB5F86982A Q33727031-567867F9-4B7D-46A5-8A7F-99764C0D212D Q33987004-3180B67E-1A9A-455B-B7EE-928AF2A89DA6 Q34074335-093362A3-C544-41AA-AF0C-374804F153C5 Q34300257-BD9C070B-2791-4757-AF15-D9F041DBD2B6 Q34416422-E35327AC-11C6-476D-81EE-CF218EE2E37D Q34878637-3531AC22-3EE0-48F6-BACD-1ABBFF8F47D6 Q35210023-35549BA6-161C-4D86-AF4B-516E7629372E Q35458969-B35BD685-C9B5-494D-B510-12DDD246F8CD Q35925357-205A82F6-98F0-42C5-9C8E-1CAC9BB7AAF2 Q36183887-AA63E3E9-5A42-409B-B08F-2D0F823994E2 Q36328530-AC45B97C-9B7E-4B9E-852B-B0089CC1E3DB Q36414175-51626B29-F699-40B0-9D8C-8AE81E8B6F24 Q36417658-DBDCDEFD-D864-4939-A066-A3E698F021E9 Q36661722-3C0F9DB2-3237-4E84-BEFA-B62F2B9AD1A6 Q36676421-60B72BF5-5DA1-474E-83BC-66AAADD9686A Q36752040-F7863109-BA44-4F7E-8006-4C719F588ADA Q36795404-B59846F9-7906-4065-AA29-3FFC346063AC Q36836697-8ADC9D50-60A3-414C-90E3-3BCAE0CBA43E Q36859555-F5B8F963-CB82-426D-833B-C63F45F28F05 Q36964693-9ED9EF02-A0A0-4DBB-B0C3-152512CE12D1 Q36974700-958B930B-A8EA-4F5A-9A9B-3D7AD8174752 Q37010188-1BC97DF3-0CCD-490E-85CA-8FEFFCDE42EF Q37157524-A481141A-B4A6-4132-AABE-B07EB1B0BEDE Q37182794-EB52F9FC-2010-4E3A-8949-CA8914604922 Q37187131-D6FE7267-8597-4B55-97B0-61F46DED701C Q37306048-35424F0D-7FAA-4A0A-B99B-00BC828F6C35 Q37728618-34910205-E2DA-4319-8AA0-C10440A64BDA Q37847515-CF6E4757-CCBE-426B-884D-4431BF4A8F72 Q38468979-9356D775-31B5-4D43-B2BD-441F9B11DA4C Q38986353-D3D3E737-87F3-473E-AEDF-8D320BCC6518 Q39502492-DF4382A2-304E-4D37-99F1-5F0B90FD445C Q39581456-6EED35A3-3EB4-40F6-897C-6176D8AB3771 Q39639581-0EA5F7AA-BA1D-4AB7-9FF6-9FAADFA78B08

P2860

PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer

http://www.wikidata.org/entity/Q34768343

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@ast

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@en

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@nl

type

label

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@ast

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@en

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@nl

prefLabel

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@ast

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@en

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@nl

P1433

Q34768343-74DB0B7A-CFA3-44D8-92BA-E9941119C906

P1476

Q34768343-314FC49B-84C9-472B-A949-A1AA8DB9ABAD

P2093

Q34768343-14D03F4B-155A-4288-AEF0-D979E1A38B29

Q34768343-54191E67-4284-4F6B-92E7-CC4D48F89D9B

Q34768343-61F54304-798F-464F-9E38-CD55F026E592

Q34768343-647BDC61-B4CF-4231-8968-49A6869E7F9E

Q34768343-A434EFAF-9B1A-47D0-8755-EB1E9C91F4E8

P2860

Q34768343-06CAE1E6-37E1-45C3-A6D7-D14DE12B1575

Q34768343-12B29B34-ABED-471A-873E-3D134A7C807A

Q34768343-13F82239-1D0C-41E8-89AB-3B4C48890DBB

Q34768343-1DA94B8E-A7FC-4FAB-AE23-7CDF23237574

Q34768343-1EC122F0-2F04-4922-BFDE-308C354C89AE

Q34768343-205EF05B-0438-4B99-8F09-11EABC31E72A

Q34768343-2629DBFA-91DF-4B21-99DB-8D873DB4F778

Q34768343-293B5DE8-0CD5-4F4C-BE2D-E1F0F1427772

Q34768343-3135A5F4-5C6A-4BCE-B398-9E94D84DDA0C

Q34768343-4F742262-E030-470B-AB54-96D5E1A72A43

P304

Q34768343-AD05C3C7-8DE2-4D18-9FC8-A92270525087

P31

Q34768343-C8ABB85C-6B0A-43C4-8374-D0781C22E3D3

P356

Q34768343-86DA3D19-881B-4BED-953A-EC70514D20B4

P433

Q34768343-02ADDFB9-C178-4BFB-A7B2-A8516FCD7F6A

P478

Q34768343-5F991EAC-4E8F-4A41-AA5B-8894F76219E7

P50

Q34768343-CE2E4B84-38FA-4CB5-868D-EE34A786860F

P577

Q34768343-7F4E7B09-72DA-47DA-8B37-548A6420518C

P5875

Q34768343-CCB8EE9E-AE4E-4BE9-898C-9941D0F076F0

P698

Q34768343-BECAA252-BC05-47CF-A111-7E80C6EB6398

P932

Q34768343-54B905E1-5599-497A-871E-36532EC46B49

P356

P1433

P1476

PPAR-gamma activation inhibits ...... in non-small cell lung cancer

@en

P2093

Douglas A Arenberg

http://www.w3.org/2001/XMLSchema#string

Michael J Newstead

http://www.w3.org/2001/XMLSchema#string

Raju C Reddy

http://www.w3.org/2001/XMLSchema#string

Shalini Anthwal

http://www.w3.org/2001/XMLSchema#string

Theodore J Standiford

http://www.w3.org/2001/XMLSchema#string

P2860

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

Characterization of two high affinity human interleukin-8 receptors

Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway

The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 re

Cloning of complementary DNA encoding a functional human interleukin-8 receptor

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

NF-kappaB in cancer: from innocent bystander to major culprit

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

P304

294-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.04601

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Venkateshwar G Keshamouni

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7935856

http://www.w3.org/2001/XMLSchema#string

P698

15799829

http://www.w3.org/2001/XMLSchema#string

P932

1501135

http://www.w3.org/2001/XMLSchema#string